ALK ‐rearranged squamous cell carcinoma of the lung-Reference-Cited by-同舟云学术

ALK ‐rearranged squamous cell carcinoma of the lung

Published:2021-02-09 Issue:7 Volume:12 Page:1106-1114
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Meng Qiyi¹,Dong Yujie²,Tao Hong¹,Shi Liang¹,Tong Li¹,Tang Junfang¹,Zhang Shucai¹,Liu Zhe¹

Affiliation:

1. Department of Medical Oncology, Beijing Chest Hospital Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing China

2. Department of Pathology, Beijing Chest Hospital Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13818

Reference38 articles.

1. Cancer statistics, 2019

2. Lung cancer epidemiology: contemporary and future challenges worldwide

3. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

5. Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation;Thoracic Cancer;2024-09-10

2. Efficacy analysis of ALK inhibitors for treating lung squamous carcinoma patients harboring ALK rearrangement;Journal of Thoracic Disease;2024-07

3. Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failure;Frontiers in Immunology;2024-02-06

4. Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach;Translational Oncology;2023-09

5. Case Report: Response to ALK-TKIs in a metastatic lung cancer patient with morphological heterogeneity and consistent molecular features;Frontiers in Oncology;2023-08-11